RecruitingNot Applicable

Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis

United States, France100 participantsStarted 2024-06-14

Plain-language summary

The purpose of this study is to characterize and assess the evolution of hearing impairment of patients with adulthood-onset bilateral sensorineural hearing loss carrying mutations on GJB2 gene.

Who can participate

Age range

30 Years – 55 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Female or Male patients ≥30 and ≤55 years old
. Bilateral hearing loss first noticed after the age of 16 years old
. Documented genotyping results showing mutations in GJB2 gene.

Exclusion criteria

. Deafness with a known, non-genetic cause
. To the opinion of the investigator, unable and/or unwilling to comply with all the protocol requirements and/or study procedures

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Evolution of hearing impairment of adult patients with early-onset presbycusis carrying mutations in GJB2 gene.

Timeframe: 2 years

Evolution of hearing impairment of adult patients with early-onset presbycusis carrying mutations in GJB2 gene

Timeframe: 2 years

Trial details

NCT IDNCT06354010

SponsorSensorion

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2027-07

Contact for this trial

Lionel HOVSEPIAN, MD

+33786311376 lionel.hovsepian@sensorion-pharma.com

View on ClinicalTrials.gov More Sensorineural Hearing Loss, Bilateral trials